The immature cells circulating in the blood of leukemic patients are believed to reflect the proliferative activity of the malignant tissue. The rate of DNA synthesis by these cells may provide information as to the rate of growth of leukemic cells, since the DNA synthetic period is believed to occupy a specific interval in the generation cycle of dividing cells. This report gives our findings concerning this parameter of leukemic proliferation, as reflected by the uptake of isotopes into leukemic cell DNA in vitro. The (1, 2). DNA extraction from the cell populations was performed by a modification of the method of Kirby (3). After separation, the leukocytes were washed with 1 per cent citric acid to remove the bulk of hemoglobin and cytoplasm. They were then homogenized in the cold in 6 per cent para-aminosalicylate (PAS) and extracted with an equal volume of phenol (88 per cent) at room temperature for 1 hour. The material was centrifuged in the cold for 1 hour and the top layer, containing DNA, removed. The DNA was precipitated with equal volumes of absolute isopropyl alcohol, resuspended in water, and reprecipitated after the addition of PAS to 6 per cent with 0.54 vol of isopropyl alcohol. The final precipitation was carried out with isopropyl alcohol (0.54 vol) from a 4 per cent sodium acetate solution of the DNA. The reprecipitations provided a final yield of about 60 per cent of the original DNA, with negligible contamination with RNA phosphorus and other non-DNA phosphorus. This procedure also effectively removed any tritium not in DNA and reduced the variables of quenching to a minimum. It was our experience that attempts to quantitate H'TDR uptake into DNA by counting whole cells or cell fractions (e.g., nuclei) resulted in such highly variable quenching, self-absorption, and non-DNA H' contamination that results were difficult to interpret. The isolated DNA, on the other hand, did not exert more quenching than the water solvent at a concentration range up to four times that employed in the experiments.
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The extracted HW-labeled DNA, dissolved in water, was suspended in a scintillator system composed of the following: Hyamine chloride (Rohm & Haas), recrystallized in toluene, 50 g; Thixin (Baker Castor Oil Co., Los Angeles), 30 g; PPO (2,5-diphenyloxazole), 4 g; POPOP [ 1,4-bis-2(5-phenyloxazolyl)-benzene], 100 mg; toluene, 1.54 L (19 ml of this system will hold 0.5 ml of the aqueous sample). Sample volumes of 0.1 or 0.2 ml were employed. Counting time was sufficiently long to give results reproducible within 1 per cent, and quenching was determined on sufficient samples to confirm the fact that it was constant. Counting efficiency with this technique was between 8 and 9 per cent. DNA-P' specific activity was determined by windowless, gas-flow counting, as previously described (1) . Specific In the results below, the radioautographic data were determined after 3 hours' incubation with H3TDR. Results after 1 hour and 19 hours were essentially the same.
RESULTS
The time course of H3TDR and P32 uptake into DNA by the same cell population, under identical conditions, differs in every cell system yet studied. Some examples of this are shown in Figure 1 . The initial uptake of H3TDR is more rapid, the curve tending to plateau after the first hour. p32 uptake follows a more exponential curve, as would be expected if the endogenous rate of DNA synthesis in the continued presence of the label is not being altered by the experiment.
The results of in vitro labeling of DNA by H3TDR and p32 are shown in Tables I, II , and III. The radioautographic data provide, in some instances, an indication of the fraction of each cell population studied that is participating in DNA synthesis. However, it will be noted that, in some cases of myeloblastic leukemia (AMB), and many of lymphoblastic (ALB) and myelomonoblastic (AMMB) leukemia, the grain count per labeled cell was so low that grain counts could not be accurately expressed (i.e., many cells with labeling only questionably above background). Nevertheless, it is probable that this pattern of low labeling by many cells is the true pattern of DNA labeling in many acute leukemias, in view of the significant and occasionally marked uptake of the labels into DNA by the population as a whole. It may be argued that the failure to see highly labeled cells under these circumstances is due to some peculiar physical property of the leukemic cells that prevents the weak beta emission of tritium from reaching the photographic film. However, the frequency with which this pattern was observed in different types of leukemic populations, as well as correlation with the data obtained from extracted DNA, suggests that it is not the result of such technical factors.
In those instances where possible, The results with radioautographic quantitation of DNA labeling with H3TDR, have been correlated, where possible, with p32 and H3 labeling of DNA, as determined by chemical extraction.
If the specific activity of the DNA label, as determined by extraction of the DNA from the entire cell sample, is expressed in terms of those cells theoretically capable of division (i.e., immature cells which can synthesize DNA), the differences between CML cells and acute leukemic cells become quite marked (Figure 2 ).
Three patients with CML have been studied serially during the transition from the chronic to the acute form of the disease. Each has shown a change in the labeling pattern to that seen in PT Figure 3 . The effect of therapy on the DNA labeling process has been extremely variable in our hands. In the acute leukemias, our data are insufficient to be definitive, but 6-mercaptopurine (6-MP) has had no consistent effect on H3TDR labeling, provided immature cells are still present. Myleran (busulfan) therapy in CML has, in most instances, suppressed DNA synthesis before any appreciable alteration in the blood picture. In one patient, who was followed serially during the favorable response to X-ray directed to the spleen only, the total white blood cells and the percentage of immature cells fell steadily, but those immature cells remaining showed the same pattern of DNA labeling observed before therapy ( Figure  4 ).
Additional data concerning the effect of X-ray on H3TDR uptake are shown in Table IV Previous studies of patients with acute leukemia, employing P32 labeling of leukocytes in vivo, have shown a prolonged persistence of the DNA label (1, 2, 5 ). An example of this in a patient with established myeloblastic leukemia (Patient 3, Table I ) is shown in Figure 5 . The fall in white blood cell count shown was a result of 6-MP therapy, with no concomitant fall in the DNA label in the population as a whole. This phenomenon could be explained in several ways: 1) the cells that incorporate the label soon after its injection remain in the circulating blood for a long time, without dividing; 2) the labeled cells divide many times, the DNA label being retained by successive generations; 3) the labeled DNA is reutilized as such, hence, is not lost with the death of the labeled cell.
This last possibility would seem unlikely as a major factor in DNA metabolism, since labeling would have been blocked by the reutilized, unlabeled DNA at the time the isotope was given. The data presented in this report and in those of others (6) would support the first explanation, since they do not indicate a rapid generation time for the bulk of leukemic blasts in the circulation. The type of data shown in Figure 5 -i.e., the persistence of the DNA label, in spite of interference with growth processes by 6-MP-is difficult to explain by any mechanism other than prolonged survival of some of the immature cells which initially acquired the DNA label.
Our studies on leukemic cells in marrow preparations, like those of Gavosto, Maraini and Pileri (6), show similar results with cells from the marrow environment. Therefore, the apparently paradoxical situation exists in some acute leukemias of a rapidly expanding cell population, but a slow reproductive rate per cell. Indeed, the majority of acute leukemic cells, capable of eventual division, are in the "resting" or G-1 (interphase) state at any one time. When one considers the enormous bulk of potentially divisible leukemic cells, and the fact that, with logarithmic growth, one cell will provide 4.295 X 109 cells after 32 divisions, it is not difficult to reconcile these findings. The intermitotic interval of acute leukemic cells could be many times longer than that of normal precursors and still retain a marked growth advantage because of: 1) the massive numbers of potentially divisible cells; 2) the failure of maturation of leukemic blasts and retention of "stem cell" proliferative capacity; and 3) the indefinite longevity of the leukemic blast, as contrasted with the short survival time of normal granulocytes.
This interpretation would be consonant with the findings of a low mitotic index and stathmokinetic index in acute leukemia (7) , without assuming that most acute leukemic cells cannot divide at all. If the mitotic time (i.e., the time the cell is in visible mitosis) of leukemic cells undergoing division is approximately the same as that for normal cells (45 minutes), the markedly prolonged G-1 period would reduce proportionately the number of mitoses visible at any one moment.
The findings, with respect to DNA synthesis by immature cells in CML blood, are similar to those of others and are comparable to the kinetics of normal granulocytic precursors in the marrow. This "extension" of the marrow precursors into the blood and tissues in CML would explain both the in vitro findings reported here and the in vivo data previously presented (1, 2, 5). Similarly, from a kinetic viewpoint, the picture in CLL seems to be an expansion of the normal proliferative lymphatic activity. In both CML and CLL, there is found a relatively small portion of immature cells, rapidly growing, maturing, functioning, and dying, along roughly normal lines. Both of these conditions would be expected to respond quickly to X-ray or radiomimetic drugs. Acute leukemia, on the other hand, would be expected to be resistant to this type of therapy, since the majority of the cells capable of proliferation are in a "resting" state at any one moment. However, when acute leukemic cells are eliminated by some other means (i.e., adrenal steroids, antimetabolites), the remaining leukemic cells are "outgrown" by the remaining normal precursors, which have an inherently shorter generation time. Eventually, the leukemic cells will reassume numerical superiority.
These data lend support to the widely accepted view that the acute leukemias represent a basic disturbance in cell maturation and are quite different from the chronic leukemias in pathogenesis.
The data on the kinetics of H3TDR and P32 labeling of DNA indicate a difference in the rate of uptake of the two labels into DNA ( Figure  1 (13) suggests that thymidine may induce the appearance of these kinases. Additional evidence for this from another approach is the work of Greulich, Cameron and Thrasher, which shows an increase in mitotic index in mouse intestinal mucosa after thymidine injection (14) .
This influence of thymidine on DNA synthesis must be considered in any study of DNA synthesis rate, and it is apparent that the rate of uptake of thymidine soon after inoculation of a cell population is not a measure of endogenous DNA synthesis. Rather it is a reflection of several factors, among which are: 1) the extent of intracellular pools of deoxycytidine, deoxyguanosine, and deoxyadenosine; 2) the activity of the phosphorylating kinases within the cell; and 3) the activity of DNA polymerase.
In spite of these difficulties in using H3TDR incorporation into DNA as a rate indicator, there was good agreement between the P32 and H3 DNA labeling after 3 hours' incubation, in all instances where the studies were done before the institution of therapy with 6-MP or other agents. In four instances in which the cells were collected soon after the institution of 6-MP therapy, the P32 uptake was suppressed more than was the H3TDR uptake, an effect which might be expected from this drug. The results to date, therefore, indicate that the extent of DNA labeling with H3TDR after 3 hours, rather than the rate at which H3TDR enters DNA, reflects the ability of the cell to perform the last steps of DNA synthesis, in the absence of factors which would interfere with earlier steps in purine and pyrimidine metabolism.
The paucity of highly labeled cells in some acute leukemic populations is noteworthy in this regard. Assuming that this finding is not due to an artifact, as previously considered, it is difficult to explain on any basis other than a long over-all DNA synthetic period. (15) , and this could be the case regardless of the duration of the S period.
Additional evidence of the low proliferative activity of some acute leukemic cells (in ALB and AMMB) has been obtained by assays of the extent of DNA polymerization in ultracentrifuged extracts of cells, employing a modification of the method described by Smellie, Kier and Davidson (16) . The results, which will be reported separately, indicate a low activity of one or more enzymes concerned with nucleotide polymerization into DNA (thymidine kinase, thymidine-5'-phosphate kinase, thymidine-5'-pyrophosphate kinase or polymerase) in ALB and AMMB cells, as compared with CML cells and normal myeloid and lymphoid precursors.
It cannot be overemphasized that thymidine uptake into DNA reflects only the last steps of DNA synthesis and, in short-term incubations, does not depend upon on-going DNA synthesis at an earlier level. Indeed, polymerization of DNA will occur in in vitro systems without the presence of cells, as discussed above. Injury to the cell, which is sufficient to lead to its destruction, as by X-ray, will not necessarily curtail this phase of DNA synthesis. The work of Das and Alfert (17) indicates that H3TDR incorporation is actually increased by irradiation. These authors employed onion-root tip cells, and the observations with canine lymphocyte precursors reported herein would support these findings. The relevance of these data to the present subject is to emphasize the pitfalls one may encounter in the interpretation of this phenomenon and the need to relate it to other parameters of cell viability and proliferative activity.
SUMMARY AND CONCLUSIONS
A technique for quantitating the uptake of p32 and H3TDR into DNA of normal and leukemic blood cells in vitro is described. Correlation of the extent of DNA labeling by these two isotopes with cell morphology and radioautographic determination of cell labeling suggests that, in many instances, leukemic blast cells have a much longer generation time than do normal or chronic leukemic precursor cells. In some instances, the majority of leukemic blasts are in interphase (G-1) at any one moment. The slow proliferative rate and the failure of cell maturation and differentiation impart a prolonged "survival" time to leukemic blasts compared with normal, "expendable" leukocytes.
Distinct differences between the rate of uptake of H3TDR and P32 were observed in all cell systems studied. The implications of these differences and the influence of thymidine on DNA polymerization are discussed. The alteration of DNA synthesis rate at various stages of the leukemic process and the influence of therapy on the phenomenon are described briefly.
